Barramundi Group (BARRA) investor relations material

Executive summary

• Achieved significant improvements in biological performance and operating discipline in Brunei aquaculture operations, with a 75% year-on-year reduction in fish mortality expense and lower fair-value loss on biological assets.

• Continued expansion of Pelong Rocks infrastructure and proactive risk management, including accelerated harvests to mitigate environmental threats.

• Advanced research collaborations and biosecurity initiatives, including new broodstock quarantine facilities and vaccine trials.

• Launched direct-to-consumer online store in Brunei and strengthened commercial channels.

• Engaged in strategic food security initiatives with Brunei and Singapore, reinforcing the group's relevance in regional agri-food development.

Financial highlights

• Revenue for 1H 2026 was $6.45 million, down from $7.15 million in 1H 2025.

• Net loss for 1H 2026 was $1.89 million, a significant improvement from a $3.88 million loss in 1H 2025.

• Fish mortality expense dropped to $0.28 million from $1.13 million year-on-year.

• Operating cash flow was negative $1.59 million, compared to positive $1.76 million in 1H 2025.

• Cash and cash equivalents increased to $2.74 million as of 30 June 2026, up from $2.16 million at year-end 2025.

Outlook and guidance

• Management remains cautious due to ongoing biological risks, particularly LCHV, and will continue to pursue multi-pronged strategies including vaccine development, biosecurity, and land-based RAS expansion.

• Focus on rebuilding production capacity with disciplined capital deployment and risk management.